
|Articles|September 20, 2017
Industry Survey Reveals Clinical Data Management Delays are Slowing Study Completion
Advertisement
A survey recently completed by the industry revealed that the time it takes companies to design and release clinical study databases is having a negative impact on the completion of trials. The delays around the database lead to increased time for other data management processes which ultimately contributes to the slowing of study completion all together.
Read the full release
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Report: Richard Pazdur Out as Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
5





